Dow Jones U.S. Pharmaceuticals Index

D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Phibro Animal (L, US)  Pharmaceuticals
1. Phibro Animal (L, US)   Pharmaceuticals	91		31		25		56
2. Akorn (M, US)  Pharmaceuticals
2. Akorn (M, US)   Pharmaceuticals	76		78		46		67
3. SciClone Pharmaceuticals (S, US)  Pharmaceuticals
3. SciClone Pharmaceuticals (S, US)   Pharmaceuticals	73		67		46		56
4. Pernix Therapeutics (S, US)  Pharmaceuticals
4. Pernix Therapeutics (S, US)   Pharmaceuticals	56		1		62		22
5. AbbVie (XXL, US)  Biotechnology
5. AbbVie (XXL, US)   Biotechnology	51		88		16		58

January 6, 2017. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Heska (S, US)   Pharmaceuticals
1. Heska (S, US)   Pharmaceuticals	17		94		25		56
2. Amphastar (M, US)   Pharmaceuticals
2. Amphastar (M, US)   Pharmaceuticals	49		89		31		56
3. AbbVie (XXL, US)   Biotechnology
3. AbbVie (XXL, US)   Biotechnology	51		88		16		58
4. Akorn (M, US)   Pharmaceuticals
4. Akorn (M, US)   Pharmaceuticals	76		78		46		67
5. SciClone Pharmaceuticals (S, US)   Pharmaceuticals
5. SciClone Pharmaceuticals (S, US)   Pharmaceuticals	73		67		46		56
6. Zoetis (XL, US)   Pharmaceuticals
6. Zoetis (XL, US)   Pharmaceuticals	39		67		31		44
7. Impax Laboratories (M, US)   Pharmaceuticals
7. Impax Laboratories (M, US)   Pharmaceuticals	46		67		15		44
8. Johnson & Johnson (XXL, US)   Pharmaceuticals
8. Johnson & Johnson (XXL, US)   Pharmaceuticals	39		66		24		40
9. Merck & Co. (XXL, US)   Pharmaceuticals
9. Merck & Co. (XXL, US)   Pharmaceuticals	30		62		76		72
10. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
10. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals	17		60		94		74

January 6, 2017. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Vivus (XS, US)   Pharmaceuticals
1. Vivus (XS, US)   Pharmaceuticals	41		22		100		56
2. Nektar (L, US)   Pharmaceuticals
2. Nektar (L, US)   Pharmaceuticals	15		22		100		44
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals	17		60		94		74
4. Merck & Co. (XXL, US)   Pharmaceuticals
4. Merck & Co. (XXL, US)   Pharmaceuticals	30		62		76		72
5. Eli Lilly (XXL, US)   Pharmaceuticals
5. Eli Lilly (XXL, US)   Pharmaceuticals	19		22		73		26
6. Endocyte (XS, US)   Pharmaceuticals
6. Endocyte (XS, US)   Pharmaceuticals	18		1		67		10
7. Pernix Therapeutics (S, US)   Pharmaceuticals
7. Pernix Therapeutics (S, US)   Pharmaceuticals	56		1		62		22
8. Pfizer (XXL, US)   Pharmaceuticals
8. Pfizer (XXL, US)   Pharmaceuticals	36		52		55		50

January 6, 2017. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined	VALUEVVV		GROWTHVV		SAFETYVV		COMBINED
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals	17		60		94		74
2. Merck & Co. (XXL, US)   Pharmaceuticals
2. Merck & Co. (XXL, US)   Pharmaceuticals	30		62		76		72
3. Akorn (M, US)   Pharmaceuticals
3. Akorn (M, US)   Pharmaceuticals	76		78		46		67
4. AbbVie (XXL, US)   Biotechnology
4. AbbVie (XXL, US)   Biotechnology	51		88		16		58
5. SciClone Pharmaceuticals (S, US)   Pharmaceuticals
5. SciClone Pharmaceuticals (S, US)   Pharmaceuticals	73		67		46		56
6. Amphastar (M, US)   Pharmaceuticals
6. Amphastar (M, US)   Pharmaceuticals	49		89		31		56
7. Vivus (XS, US)   Pharmaceuticals
7. Vivus (XS, US)   Pharmaceuticals	41		22		100		56
8. Phibro Animal (L, US)   Pharmaceuticals
8. Phibro Animal (L, US)   Pharmaceuticals	91		31		25		56
9. Heska (S, US)   Pharmaceuticals
9. Heska (S, US)   Pharmaceuticals	17		94		25		56
10. Pfizer (XXL, US)   Pharmaceuticals
10. Pfizer (XXL, US)   Pharmaceuticals	36		52		55		50

January 6, 2017. Top 10s are published weekly by Top 10 schedule. (Free Stock Update)

☀ This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from January 6, 2017.